Oncodesign Société Anonyme

DB:16O Stock Report

Market Cap: €99.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Oncodesign Société Anonyme Management

Management criteria checks 1/4

Key information

Philippe Genne

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12.6yrs
CEO ownershipn/a
Management average tenure8.6yrs
Board average tenureno data

Recent management updates

Recent updates


CEO

Philippe Genne

12.6yrs

Tenure

€204,420

Compensation

Dr. Philippe Genne, Ph D., Founded Oncodesign Société Anonyme, serves as its Chairman of the Board and has been its Chief Executive Officer since May 18, 2010 and Chief Corporate Business Development Offic...


Leadership Team

NamePositionTenureCompensationOwnership
Philippe Genne
Founder12.6yrs€204.42kno data
Arnaud Lafforgue
Chief Financial & Administrative Officer4.7yrsno datano data
Jan Hoflack
Chief Scientific Officerno datano datano data
Catherine Genne
Deputy Managing Directorno data€24.34kno data
Olivier Duchamp
Member of Executive Board14.9yrsno datano data
Francis Bichat
Member of Executive Board14.9yrsno datano data
Karine Lignel
Chief Operating Officerless than a yearno datano data
Stephane Gerart
Chief Information Officer & Head of Artificial Intelligence2.3yrsno datano data
Sylvie Forster
Chief Legal Officerno datano datano data
Thierry Billoue
Chief Human Resources Officerno datano datano data

8.6yrs

Average Tenure

52yo

Average Age

Experienced Management: 16O's management team is seasoned and experienced (8.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/23 16:01
End of Day Share Price 2022/12/09 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oncodesign Société Anonyme is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gary WaandersBryan Garnier & Co
Victor FlochBryan Garnier & Co
Fanny MeindreCIC Market Solutions (ESN)